Storage stable liquid sealer protein complex
OwnerColin John Newton, Thomas Seelichinventors
Life of this patent
Estimating the term…
Abstract
The present invention provides storage stable liquid sealer protein complexes containing fibrinogen that are convenient to store and transport, that are stable over several months, and that do not have to be discarded if an intended surgical procedure is not carried out. The complexes of the invention comprise fibrinogen, an anti-proteolytic agent, an anti-gelling agent, and a physiologically acceptable carrier.
Claims25
A composition of a storage stable liquid sealer protein, the composition comprising:
- fibrinogen;
- an anti-proteolytic agent;
- an anti-gelling agent;
- an antioxidant agent;
- and a physiologically acceptable carrier.
A composition of a storage stable liquid sealer protein complex, the composition comprising:
- fibrinogen at a concentration of about 60-110 mg/ml;
- about 45-50 mM arginine, neutralized to pH 7.3 with citric acid;
- about 5 mM glutathione;
- about 5-10 μM alpha 2 antiplasmin;
- at least 3 U of Factor XIII per 100 mg of sealer protein;
- and a physiologically acceptable carrier.
A composition of a storage stable liquid sealer protein complex, the composition comprising:
- fibrinogen at a concentration of about 60-110 mg/ml;
- about 45-50 mM arginine, neutralized to pH 7.3 with citric acid;
- about 5 mM glutathione;
- about 5-10 μM alpha 2 antiplasmin;
- about 45-70 μM aprotinin;
- at least 3 U of Factor XIII per 100 mg of sealer protein;
- and a physiologically acceptable carrier.
A composition of a storage stable liquid sealer protein complex, the composition comprising:
- fibrinogen at a concentration of about 60-110 mg/ml;
- about 45-50 mM arginine, neutralized to pH 7.3 with citric acid;
- about 5 mM glutathione;
- about 20-30 μM alpha 1 protease inhibitor;
- about 45-70 μM aprotinin;
- at least 3 U of Factor XIII per 100 mg of sealer protein;
- and a physiologically acceptable carrier.
A composition of a storage stable liquid sealer protein complex, the composition comprising:
- fibrinogen at a concentration of about 60-110 mg/ml;
- about 45-50 mM arginine, neutralized to pH 7.3 with citric acid;
- about 5 mM glutathione;
- about 20-30 μM antithrombin III;
- about 10-15 μM heparin;
- about 45-70 μM aprotinin;
- at least 3 U of Factor XIII per 100 mg of sealer protein;
- and a physiologically acceptable carrier.
A method of making a storage stable liquid fibrinogen composition, said method comprising the step of:
- reconstituting protein comprising fibrinogen in an aqueous solution comprising an anti-proteolytic agent, an anti-gelling agent, an antioxidant, and a physiologically acceptable carrier.
Dependencies are inferred from the claim text.